Clinical Trial Update: Effect of Standard of Care Reduced Dose Versus Full Dose Buprenorphine/Naloxone in the Perioperative Period on Pain Control and Post-Operative Opioid Use Disorder Symptoms [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating reduced-dose versus full-dose buprenorphine/naloxone in the perioperative period was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Buprenorphine/naloxone (buprenorphine/naloxone)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Opioid-use Disorder, Opioid Use Disorder, Mild | Phase 4 | Status: WITHDRAWN